Concepedia

Author

Johannes Brägelmann

University of CologneORCID

Also Known As

Brägelmann, Johannes, BräGelmann, Johannes, Florian Klein, J Brägelmann, J. Brägelmann, Jennifer Landsberg, Johannes Bragelmann, Johannes Brgelmann, Johannes Brägelmann, Oksana Lewandowska

195

Publications

4.3K

Citations

29

H-Index

60

Concepts

All Affiliations

University of CologneUniversity Hospital CologneUniversity Hospital BonnResearch Center Borstel - Leibniz Lung CenterHeidelberg University
JB

About

Johannes Brägelmann is an author at University of Cologne specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

978

2

Engineering

2

2

325

3

Health Sciences

1

1

44

4

Natural Sciences

1

1

20

5

Public Health

1

1

15

Johannes Brägelmann

×

46

Publications

4.1K

Citations

28

H-Index

YearCitations

Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas

Tanguy Y. Seiwert, Zhixiang Zuo, Michaela K. Keck,

Clinical Cancer Research

2014

647

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Gürkan Mollaoglu, Matthew R. Guthrie, Stefanie Böhm,

Cancer Cell

2017

570

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes

Michaela K. Keck, Zhixiang Zuo, Arun Khattri,

Clinical Cancer Research

2014

378

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein,

Journal of Thoracic Oncology

2018

247

FirebrowseR: an R client to the Broad Institute’s Firehose Pipeline

Mario C. Deng, Johannes Brägelmann, Ivan Kryukov,

Database

2016

222

Web-TCGA: an online platform for integrated analysis of molecular cancer data sets

Mario C. Deng, Johannes Brägelmann, Joachim L. Schultze,

BMC Bioinformatics

2016

215

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Jana Fassunke, Fabienne Müller, Marina Keul,

Nature Communications

2018

139

Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation

Fabienne Müller, Jonathan Lim, Christina M. Bebber,

Cell Death and Differentiation

2022

116

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer

Johannes Brägelmann, Niklas Klümper, Anne Offermann,

Clinical Cancer Research

2016

112

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma

Tim Müller, Martin Braun, Dimo Dietrich,

Oncotarget

2017

110

Page 1